Radioimmunoguided surgery benefits in carcinoembryonic antigen-directed second-look surgery in the asymptomatic patient after curative resection of colorectal cancer

Seminars in Surgical Oncology

Volumn 15, Issue 4, 1998, Pages 263-267

  Bertoglio, Sergio ^a   Benevento, Angelo ^b   Percivale, Pierluigi ^a   Cafiero, Ferdinando ^a   Moresco, Luciano ^a   Peressini, Alberto ^a   Dionigi, Renzo ^b   Badellino, Fausto ^c  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Adenocarcinoma; Carcinoembryonic antigen; Colonic neoplasms; Colorectal neoplasms; Intraoperative period; Iodine radioisotopes; Local neoplasm recurrence; Monoclonal antibodies; Neoplasm metastasis; Neoplasm staging; Patient selection; Radioimmunodetection; Rectal neoplasms; Reoperation

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; IODINE 125; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY B.72.3; SURGIMAB R3; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN DETECTION; CANCER INVASION; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CANCER; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSCINTIGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; LIVER METASTASIS; MALE; PRIORITY JOURNAL; RADIOSURGERY; RECURRENT CANCER; SECOND LOOK SURGERY;

EID: 0031789779     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2388(199812)15:4<263::AID-SSU15>3.0.CO;2-Q     Document Type: Conference Paper

References (23)

1. August DA, Ottow RT, Sugarbaker PH: Clinical perspective of human colorectal cancer metastasis [Review]. Cancer Metast Rev 1984;3:303-324
2. Galandiuk S, Wieand HS, Moertel CG, et al: Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obstet 1992,174:27-32
3. Quentmeier A, Schlag P, Smok M, Herfarth C: Re-operation for recurrent colorectal cancer: the importance of of early diagnosis for resectability and survival. Eur J Surg Oncol 1990;16:319-325.
4. Wagensteen OH: Cancer of the colon and rectum with special reference to (1) early recognition of alimentary tract malignancy (2) secondary tract malignancy (3) secondary delayed re-entry in patients exhibiting lymph node involvement (4) subtotal primary excision of the colon (5) operations in obstruction Wisc Med J 1949;48:591-605.
5. Wagensteen OH, Lewis FJ, Tongen LA: The "second look" in cancer surgery. Lancet 1951;1:303-307.
6. Griffen WO Jr, Humphrey L, Sosin H: The prognosis and management of recurrent abdominal malignancies [Review]. Curr Probl Surg 1969;3-41.
7. Gunderson LL, Sosin H: Areas of failure found at reoperation (second or symptomatic look) after "curative surgery" for adenocarcinomas of the rectum. Cancer 1974;34:1278-1292.
8. Martin EW, Minton JP, Carey LC: CEA-directed second-look surgery in asymptomatic patients after primary resection of colorectal carcinoma. Ann Surg 1985;202:310-317.
9. Minton JP, Hoehn JL, Gerber DM, et al: Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study. Cancer 1985;55:1284-1290.
10. Staab HJ, Anderer FA, Stumpf E, Fischer R: Slope analysis of the postoperative CEA time course and its possible application as an aid in diagnosis of disease proaression in gastrointestinal cancer. Am J Surg 1978;136:322-327.
11. Sardi A: Multiple operations for recurrent colorectal cancer [Review]. Semin Surg Oncol 1991;7:146-156.
12. Dentsman F, Rosen L, Khubchandani IT, et al: Comparing predictive decision rules inpostoperative CEA monitoring. Cancer 1986;58:2089-2095.
13. Wanebo HJ: Are carcinoembryonic antigen levels of value in the curative management of colorectal cancer? Surgery 1981;89:290-295.
14. Northover JM: Carcinoembry onic antigen and recurrent colorectal cancer. Br J Surg 1985. 72 Suppl S44-S46.
15. Arnold MW, Schneebaum S, Berens A, et al: Radioimmunoguided surgery challengestraditional decision-making in patients with primary colorectal cancer. Surgery 1992;112:624-630.
16. Cohen AM, Martin EW Jr, Lavery I, et al: Radioimmunoguided surgery using iodine-125 B72.3 in patients with colorectal cancer. Arch Surg 1991;126:349-352.
17. Di Carlo V, Badellino F, Stella M, et al: Role of B72.3 iodine 125-labeled monoclonal antibody in colorectal cancer detection by radioimmunoguided surgery. Surgery 1994;115:190-198.
18. Schneebaum S, Papo J, Graif M, et al: Radioimmunoguided surgery benefits for recurrent colorectal cancer [comment in: Ann Sura Oncol 1997;4:369-370]. Ann Surg Oncol 1997;4:371-376.
19. Moertel CG, Fleming TR, Macdonald JS, et al: An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer [comments in: JAMA 1993;270:987-988; JAMA 1994;271:345-347: JAMA 1994; 272:31]. JAMA 1993;270:943-947.
20. Biggs CG, Ballantyne GH: Sensitivity versus cost effectiveness in postoperative follow-up for colorectal cancer. Curr Opin Gen Surg 1994;94-102.
21. Steele G Jr, Bleday R, Mayer RJ, et al: A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Study Group Protocol 6584 [comment in: J Clin Oncol 1991;9:2078-2079]. J Clin Oncol 1991;9:1105-1112.
22. Hafner GH, Herrera L, Petrelli NJ: Morbidity and mortality after pelvic exenteration for colorectal adenocarcinoma. Ann Surg 1992;215:63-67.
23. Bertsch DJ, Burak WE Jr, Young DC, et al: Radioimmunoguided Surgery system improves survival for patients with recurrent colorectal cancer [Review]. Surgery 1995;118:634-639.